November 14th, 2010
Emphatic Support for Eplerenone in NYHA Class II Heart Failure
Larry Husten, PHD
Aldosterone antagonists have proven beneficial in heart failure patients with moderate-to-severe symptoms and in MI patients with LV dysfunction and heart failure. Now EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure) has extended these benefits to patients with systolic HF and mild symptoms. EMPHASIS HF randomized 2737 patients with NYHA class II […]
NEJM Journal Watch — Recent Cardiology Articles- 10-Year Mortality in Patients Undergoing PCI for First-Time ST-Segment Elevation Myocardial Infarction
- Possible Connection Between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
- Does Knowledge of Asymptomatic Coronary Ischemia Improve Outcomes After Major Vascular Surgery?
- Effect of Telecardiology After Hospital Discharge for Acute Coronary Syndromes
- Intensive BP Reduction for Preventing Major Adverse Cardiovascular Events